157 related articles for article (PubMed ID: 2474812)
1. Inhibition of acetyl- and butyrylcholinesterase and amylase release from canine pancreas.
Oguchi Y; Dressel TD; Borner JW; Miller J; Goodale RL
Pancreas; 1989; 4(4):423-8. PubMed ID: 2474812
[TBL] [Abstract][Full Text] [Related]
2. Organophosphate increases the sensitivity of human exocrine pancreas to acetylcholine.
Kandalaft K; Liu S; Manivel C; Borner JW; Dressel TD; Sutherland DE; Goodale RL
Pancreas; 1991 Jul; 6(4):398-403. PubMed ID: 1715083
[TBL] [Abstract][Full Text] [Related]
3. Effect of the organophosphate iso-OMPA on amylase release by pancreatic lobules of dog, guinea pig, and cat.
Oguchi Y; Frick TW; Satterberg TL; Dressel TD; Borner JW; Goodale RL
Pancreas; 1987; 2(6):664-8. PubMed ID: 2449688
[TBL] [Abstract][Full Text] [Related]
4. Increased canine pancreatic acinar cell damage after organophosphate and acetylcholine or cholecystokinin.
Liu S; Oguchi Y; Borner JW; Runge W; Dressel TD; Goodale RL
Pancreas; 1990 Mar; 5(2):177-82. PubMed ID: 2315293
[TBL] [Abstract][Full Text] [Related]
5. Cholinesterases and contractility of cat irides. Effect of echothiophate iodide.
Harris LS; Shimmyo M; Mittag TW
Arch Ophthalmol; 1973 Jan; 89(1):49-51. PubMed ID: 4684897
[No Abstract] [Full Text] [Related]
6. Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase.
Masson P; Froment MT; Bartels CF; Lockridge O
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):53-61. PubMed ID: 9224629
[TBL] [Abstract][Full Text] [Related]
7. Effects of inactivation of butyrylcholinesterase on steady state and regenerating levels of ganglionic acetylcholinesterase.
Koelle GB; Koelle WA; Smyrl EG
J Neurochem; 1977 Feb; 28(2):313-9. PubMed ID: 839215
[No Abstract] [Full Text] [Related]
8. The relationship between innervation and the cholinesterases of the rat atrioventricular node.
Taylor IM
J Histochem Cytochem; 1977 Jan; 25(1):21-6. PubMed ID: 833422
[TBL] [Abstract][Full Text] [Related]
9. Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine.
Bitzinger DI; Gruber M; Tümmler S; Michels B; Bundscherer A; Hopf S; Trabold B; Graf BM; Zausig YA
Neuropharmacology; 2016 Oct; 109():1-6. PubMed ID: 26772968
[TBL] [Abstract][Full Text] [Related]
10. A suitable method to monitor inhibition of cholinesterase activities in tissues as induced by reversible enzyme inhibitors.
Thomsen T; Kewitz H; Pleul O
Enzyme; 1989; 42(4):219-24. PubMed ID: 2698348
[TBL] [Abstract][Full Text] [Related]
11. The relationship between cholinesterase activity and brain permeability to barbitone.
Rosić N; Milosević MP
Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):302-7. PubMed ID: 6047617
[No Abstract] [Full Text] [Related]
12. Lens organ culture. II. Pharmacologic evaluation.
Haddad HM; Furman M; Shore B
Am J Ophthalmol; 1967 Jun; 63(6):1737-43. PubMed ID: 6027350
[No Abstract] [Full Text] [Related]
13. [Organophosphorus compounds as tools for the pharmaco-histochemical study of cholinesterase in the rat striatum].
Delamanche IS; Mailly P; Bouchaud C
Arch Anat Microsc Morphol Exp; 1986-1987; 75(3):135-48. PubMed ID: 3631954
[TBL] [Abstract][Full Text] [Related]
14. Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease.
Geula C; Mesulam M
Brain Res; 1989 Sep; 498(1):185-9. PubMed ID: 2790472
[TBL] [Abstract][Full Text] [Related]
15. Degradation of acetylcholine in human airways: role of butyrylcholinesterase.
Norel X; Angrisani M; Labat C; Gorenne I; Dulmet E; Rossi F; Brink C
Br J Pharmacol; 1993 Apr; 108(4):914-9. PubMed ID: 8485630
[TBL] [Abstract][Full Text] [Related]
16. The role of cholinesterases in rat urinary bladder contractility.
Nakahara T; Kubota Y; Sakamoto K; Ishii K
Urol Res; 2003 Jul; 31(3):223-6. PubMed ID: 12736766
[TBL] [Abstract][Full Text] [Related]
17. N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine.
Cerbai F; Giovannini MG; Melani C; Enz A; Pepeu G
Eur J Pharmacol; 2007 Oct; 572(2-3):142-50. PubMed ID: 17643410
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous reactivation of organophosphorus-inhibited electroplax cholinesterase in relation to acetylcholine-induced depolarization.
Dettbarn WD; Bartels E; Hoskin FC; Welsch F
Biochem Pharmacol; 1970 Dec; 19(12):2949-55. PubMed ID: 5513033
[No Abstract] [Full Text] [Related]
19. Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase.
Wang Y; Boeck AT; Duysen EG; Van Keuren M; Saunders TL; Lockridge O
Toxicol Appl Pharmacol; 2004 May; 196(3):356-66. PubMed ID: 15094306
[TBL] [Abstract][Full Text] [Related]
20. Cholinesterase activity on Echinogammarus meridionalis (Pinkster) and Atyaephyra desmarestii (Millet): characterisation and in vivo effects of copper and zinc.
Quintaneiro C; Monteiro M; Soares AM; Ranville J; Nogueira AJ
Ecotoxicology; 2014 Apr; 23(3):449-58. PubMed ID: 24526590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
